Literature DB >> 1619851

Usefulness of hemilaminectomy for microsurgical management of intraspinal lesions.

H Bertalanffy1, S Mitani, M Otani, K Ichikizaki, S Toya.   

Abstract

Hemilaminectomy is a limited, unilateral approach to the spinal cord that provides excellent exposure of the dorsolateral and ventral portions of the spinal canal. This approach is most suitable for microsurgical management of the majority of extramedullary tumors. Contrary to conventional laminectomy, the posterior supporting structures of the spine are completely preserved on the contralateral side with this access route. The procedure has been applied in 3 patients who harbored a cervical neurilemmoma, a cervical lipoma, and a thoracic neurilemmoma, respectively. Optimal exposure of the lesion was achieved in each case, and each patient's symptoms improved or completely resolved postoperatively. There were no surgical complications. It is concluded that hemilaminectomy combined with microsurgical techniques should be given priority over standard laminectomy in the surgical management of extramedullary lesions arising in the spinal canal.

Entities:  

Mesh:

Year:  1992        PMID: 1619851     DOI: 10.2302/kjm.41.76

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  11 in total

1.  Intra-operative high frequency ultrasound improves surgery of intramedullary cavernous malformations.

Authors:  Oliver Bozinov; Jan-Karl Burkhardt; Christoph M Woernle; Vincent Hagel; Nils H Ulrich; Niklaus Krayenbühl; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2011-11-12       Impact factor: 3.042

2.  Removal of intradural-extramedullary spinal cord tumors with unilateral limited laminectomy.

Authors:  Jong-Eun Sim; Seung-Jin Noh; Young-Jin Song; Hyung-Dong Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-05-20

3.  Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features.

Authors:  U Spetzger; H Bertalanffy; B Huffmann; L Mayfrank; J Reul; J M Gilsbach
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

4.  Profiles of Spinal Cord Tumors Removed through a Unilateral Hemilaminectomy.

Authors:  Dong Kyu Yeo; Soo Bin Im; Kwan Woong Park; Dong Seong Shin; Bum Tae Kim; Won Han Shin
Journal:  J Korean Neurosurg Soc       Date:  2011-09-30

5.  Surgical results after unilateral laminectomy for the removal of spinal cord tumors.

Authors:  Jung-Heon Lee; Jae-Won Jang; Sung-Hyun Kim; Hyung-Sik Moon; Jung-Kil Lee; Soo-Han Kim
Journal:  Korean J Spine       Date:  2012-09-30

6.  Three-dimensional spiral CT for neurosurgical planning.

Authors:  H M Klein; H Bertalanffy; L Mayfrank; A Thron; R W Günther; J M Gilsbach
Journal:  Neuroradiology       Date:  1994-08       Impact factor: 2.804

Review 7.  Minimally invasive surgery for benign intradural extramedullary spinal meningiomas: experience of a single institution in a cohort of elderly patients and review of the literature.

Authors:  Maurizio Iacoangeli; Maurizio Gladi; Alessandro Di Rienzo; Mauro Dobran; Lorenzo Alvaro; Niccolò Nocchi; Lucia Giovanna Maria; Di Somma; Roberto Colasanti; Massimo Scerrati
Journal:  Clin Interv Aging       Date:  2012-12-06       Impact factor: 4.458

8.  Hemilaminectomy for removal of extramedullary or extradural spinal cord tumors: medium to long-term clinical outcomes.

Authors:  Toshitaka Naganawa; Kei Miyamoto; Hideo Hosoe; Naoki Suzuki; Katsuji Shimizu
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

9.  Surgical Excition of Spinal Intradural Meningiomas through a Single-Sided Minimally Invasive Approach: Key-Hole Laminotomy.

Authors:  Ramazan Alper Kaya
Journal:  Asian Spine J       Date:  2015-04-15

10.  Novel combination of paraspinal keyhole surgery with a tubular retractor system leads to significant improvements in lumbar intraspinal extramedullary schwannomas.

Authors:  Yuandong Zhuang; Gangfeng Cai; Chaofeng Fu; Weiqiang Zhang; Wei Zhao; Rui Wang; Chunhua Wang; Songsheng Shi; Chunmei Chen
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.